Stop overpaying - start transferring money with Ogvio. Sign up, invite friends & grab Rewards now! 🎁
Goldman Sachs AI Assistant Goes Firmwide to Boost Workflows and Speed
Key Takeaways
- Goldman Sachs is expanding its AI assistant firmwide after testing it with 10,000 employees across different departments;
- The GS AI Assistant helps with daily tasks like summarizing, translating, writing, and data analysis using approved language models;
- Tailored features support roles from coding to client work, including translation tools for wealth managers and analysts.
Goldman Sachs, an American financial services company, is making its in-house artificial intelligence (AI) assistant available to all employees, according to a June 23 report by Fox Business.
After testing the tool with 10,000 staff members, the bank has decided to expand its use throughout all departments.
The assistant, called GS AI Assistant, was designed to help employees with their daily tasks by using generative AI models. It can summarize documents, draft text, translate content, and analyze data.
Did you know?
Subscribe - We publish new crypto explainer videos every week!
What is VeChain? VeChain Coin Explainer (ANIMATED)
The tool supports different types of work, with features that adapt to the needs of developers, bankers, researchers, and client advisors.
Employees can choose from a list of approved large language models (LLMs), including GPT-4o, Claude 3.7 Sonnet, and Google’s Gemini models.
The company’s Chief Information Officer, Marco Argenti, stated in a memo that thousands of employees are already using the assistant and encouraged others to try it to improve their workflows.
One key feature added during the testing phase was the ability to translate. Wealth managers and analysts often work with clients who speak different languages. With the new tool, they can translate reports and presentations more easily.
The AI assistant also provides developers with code suggestions, while researchers can use it to highlight key points in complex reports.
On June 3, the US Food and Drug Administration (FDA) introduced Elsa, its internal AI platform. How does it work? Read the full story.